1
|
Fusco V, Cabras M, Erovigni F, Dell'Acqua A, Arduino PG, Pentenero M, Appendino P, Basano L, Ferrera FD, Fasciolo A, Caka M, Migliario M. A multicenter observational study on Medication-Related Osteonecrosis of the Jaw (MRONJ) in advanced cancer and myeloma patients of a cancer network in North-Western Italy. Med Oral Patol Oral Cir Bucal 2021; 26:e466-e473. [PMID: 33340073 PMCID: PMC8254890 DOI: 10.4317/medoral.24318] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2020] [Accepted: 11/30/2020] [Indexed: 01/02/2023] Open
Abstract
BACKGROUND Incidence of Medication-Related Osteonecrosis of the Jaw (MRONJ) related to cancer and myeloma treatments is undetermined, with scarce data varying from 2 to 7.8/million/year in limited investigated populations. A 9-years [2009-2018] regional-wide survey was conducted, deploying the North-Western Italy Cancer Network ("Rete Oncologica Piemonte e Valle d'Aosta"), to assess number and main characteristics of MRONJ cases among myeloma/cancer patients, within a population of 4.5 million inhabitants. MATERIAL AND METHODS MRONJ cases were collected retrospectively from January 2009 to June 2015; from July 2015 to December 2018, data were collected prospectively. Number of new MRONJ cases per year, underlying disorder, drug(s) administered, treatment duration, site and onset timing of MRONJ were detailed. RESULTS 459 MRONJ cases were identified. Primary diseases were breast cancer (46%), prostate cancer (21%), myeloma (19%), and other types of carcinoma (14%). Patients received antiresorptive treatment either alone (399; 88.47%) or in combination with biological agents (52; 11.53%); 8 patients (1.7%) received only antiangiogenic drugs. Zoledronic acid [388] and denosumab [59] were the most frequently administered drugs. Mandible was involved in 296 (64,5%) cases. Number of new MRONJ cases was stable from 2009 to 2015, with a mean of 51.3 cases per year (raw incidence: 11.6/million/year), declining in the 2016-2018 years to 33.3 cases per year (raw incidence: 7.5/million/year). CONCLUSIONS With such discrepancy of cases overtime being partially explicable, number of new MRONJ cases per year are consistent with those observed in a previous study [2003-2008] in the same region, being instead higher than those reported in other populations.
Collapse
Affiliation(s)
- V Fusco
- Department of Surgical Sciences CIR-Dental School, University of Turin Via Nizza 230, 10126 Turin, Italy
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
2
|
Arduino PG, Carbone M, Gambino A, Cabras M, Cannarsa F, Macciotta A, Conrotto D, Broccoletti R. Challenging management of gingival squamous cell carcinoma: a 10 years single-center retrospective study on Northern-Italian patients. Med Oral Patol Oral Cir Bucal 2021; 26:e21-e27. [PMID: 32851989 PMCID: PMC7806350 DOI: 10.4317/medoral.23913] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2020] [Accepted: 07/27/2020] [Indexed: 12/02/2022] Open
Abstract
Background Aim of this study was to describe the outcome of patients with gingival squamous cell carcinoma (GSCC), and to recognize aspects affecting clinical course and to consider survival rate.
Material and Methods The case records of patients, over a 10-year period, were retrospectively examined. Differences in distribution of the potential risk factors by prognosis were investigated through non-parametrical tests (Wilcoxon Rank-Sum and Fisher’s Exact). Survival curves for age, therapy and stage were built by the Kaplan-Meier method and compared with Log-Rank test.
Results 79 patients were analysed. Significant increase in mortality for patients older than 77 and for those with advanced stages was found. Cumulative survival rate 5 years after the diagnosis was 43%, while at 10 years was of 11%.
Conclusions With a statistical relationship between age and tumour stage with survival rates, and 70% of GSCC cases identified as stage IV, early GSCC diagnosis remains challenging. Key words:Gingival cancer, clinical appearance, treatment, retrospective study.
Collapse
Affiliation(s)
- P-G Arduino
- Department of Surgical Sciences CIR-Dental School, University of Turin Via Nizza 230, 10126 Turin, Italy
| | | | | | | | | | | | | | | |
Collapse
|
3
|
Valpreda L, Carcieri P, Cabras M, Vecchiati G, Arduino PG, Bassi F. Frequency and severity of dental caries in foster care children of Turin, Italy: a retrospective cohort study. Eur J Paediatr Dent 2020; 21:299-302. [PMID: 33337906 DOI: 10.23804/ejpd.2020.21.04.8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
AIM Aim of this retrospective cohort study was to assess the frequency and severity of dental caries (DC) among foster care children in the city of Turin, in North West Italy, and to compare these data with those of a general paediatric population. MATERIALS AND METHODS From May 2016 to September 2018, 75 paediatric subjects between the age of 4 and 12, located in 11 residential child care communities were recruited. Instructions were provided concerning oral health, caries and correlation with dietary habits. Oral and dental examination were carried out to establish frequency and severity of caries (not-penetrating, nPC, corresponding to the International Caries Detection and Assessment System (ICDAS) codes: 1-4, vs. penetrating, PC, corresponding to ICDAS codes: 5-6). Decayed, missed, filled teeth (DMFT) index was used. Data for comparison were acquired from the WHO Collaboration Center For Epidemiology and Community Dentistry of Milan (WHO-CCOMS), belonging to a nationwide sample of 2,141 Italian children. RESULTS Only 13 subjects (17%) were caries-free; 187 caries were identified: 133 were PC, whereas 54 were nPC. Overall, 76% of the caries were found in deciduous teeth. Mean DMFT was 3.43 (D = 2.97; M = 0.24; F = 0.22). When the study data were compared to those from WHO-CCOMS, a significantly higher DMFT (3.43 vs 0.96; p <0.00001) and D (2.97 vs 0.62; p <0.00001) was detected. CONCLUSION A significant higher frequency of caries in foster care children in Turin, Italy compared to the general population was detected.
Collapse
Affiliation(s)
- L Valpreda
- Oral prevention and community dentistry, CIR-Dental School, University of Turin, Turin, Italy - Private practice, Piedmont, Italy
| | - P Carcieri
- Department of Surgical Sciences, Oral Medicine Section, CIR-Dental School, University of Turin, Turin, Italy - Oral prevention and community dentistry, CIR-Dental School, University of Turin, Turin, Italy
| | - M Cabras
- Department of Surgical Sciences, Oral Medicine Section, CIR-Dental School, University of Turin, Turin, Italy
| | - G Vecchiati
- Oral prevention and community dentistry, CIR-Dental School, University of Turin, Turin, Italy
| | - P G Arduino
- Department of Surgical Sciences, Oral Medicine Section, CIR-Dental School, University of Turin, Turin, Italy
| | - F Bassi
- Oral prevention and community dentistry, CIR-Dental School, University of Turin, Turin, Italy - Department of Surgical Sciences, Prosthodontic Section, CIR-Dental School, University of Turin, Turin, Italy
| |
Collapse
|
4
|
Fusco V, Fasciolo A, Gambino A, Cabras M, Erovigni F, Bianchi C, Benzi L, De Martino I, Monaco F, Rossi M, Numico G, Carossa S. Inadequacy of current definition and staging system of Medication-Related Osteonecrosis of Jaw (MRONJ) released by AAOMS: A computed tomography study in 151 cancer and myeloma patients. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz265.040] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
5
|
Spina M, Merli F, Puccini B, Cavallo F, Cabras M, Fabbri A, Angrilli F, Zilioli V, Marino D, Balzarotti M, Ladetto M, Cox M, Petrucci L, Arcari A, Gini G, Chiappella A, Hohaus S, Musuraca G, Merli M, Sartori R, Nassi L, Tani M, Re F, Flenghi L, Molinari A, Kovalchuk S, Bottelli C, Ferrero S, Dessì D, Cencini E, Pennese E, Marcheselli L, Mammi C, Luminari S, Tucci A. THE ELDERLY PROJECT BY THE FONDAZIONE ITALIANA LINFOMI: A PROSPECTIVE COMPREHENSIVE GERIATRIC ASSESSMENT (CGA) OF 1353 ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA. Hematol Oncol 2019. [DOI: 10.1002/hon.58_2630] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- M. Spina
- Division of Medical Oncology and Immune-related tumors; National Cancer Institute; Aviano (PN) Italy
| | - F. Merli
- Hematology; Azienda USL-IRCCS; Reggio Emilia Italy
| | - B. Puccini
- Hematology Department; University of Florence and AOU Careggi; Firenze Italy
| | - F. Cavallo
- Division of Hematology; University of Torino, Azienda Ospedaliero Universitaria, Città della Salute e della Scienza di Torino; Torino Italy
| | - M.G. Cabras
- Division of Hematology; Ospedale Businco; Cagliari Italy
| | - A. Fabbri
- Unit of Hematology; Azienda Ospedaliera Universitaria Senese; Siena Italy
| | - F. Angrilli
- Lymphoma Unit, Department of Hematology; Ospedale Spirito Santo; Pescara Italy
| | - V.R. Zilioli
- Division of Hematology; ASST Grande Ospedale Metropolitano Niguarda; Milano Italy
| | - D. Marino
- Medical Oncology 1; Veneto Institute of Oncology IOV IRCCS; Padova Italy
| | - M. Balzarotti
- Department of Medical Oncology and Hematology; Humanitas, Clinical and Research Hospital-IRCCS; Rozzano (MI) Italy
| | - M. Ladetto
- Division of Hematology; A.O. SS Antonio e Biagio and Cesare Arrigo; Alessandria Italy
| | - M.C. Cox
- Hematology Unit; AOU Sant'Andrea; Roma Italy
| | - L. Petrucci
- Institute of Hematology; Dept. of Translational and Precision Medicine “Sapienza”, University of Roma; Roma Italy
| | - A. Arcari
- Haematology Unit; Azienda AUSL; Piacenza Italy
| | - G. Gini
- Division of Haematology; Ospedali Riuniti; Ancona Italy
| | - A. Chiappella
- Division of Hematology; Città della Salute e della Scienza Hospital and University; Torino Italy
| | - S. Hohaus
- Catholic University of the Sacred Heart; University Policlinico Gemelli Foundation, IRCCS; Roma Italy
| | - G. Musuraca
- Department of Hematology; Istituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori; Meldola (FC) Italy
| | - M. Merli
- Hematology, Ospedale di Circolo e Fondazione Macchi; University of Insubria; Varese Italy
| | - R. Sartori
- Hematology Department; Castelfranco Veneto Regional Hospital; Castelfranco Veneto (TV) Italy
| | - L. Nassi
- Hematology; AOU Maggiore della Carità; Novara Italy
| | - M. Tani
- Department of Hematology; S. Maria delle Croci Hospital; Ravenna Italy
| | - F. Re
- Hematology and BMT Center; Azienda Ospedaliera, University of Parma; Parma Italy
| | - L. Flenghi
- Hematology; S. Maria della Misericordia Hospital; Perugia Italy
| | - A. Molinari
- Hematology Unit; Infermi Hospital; Rimini Italy
| | - S. Kovalchuk
- Hematology Department; University of Florence and AOU Careggi; Firenze Italy
| | - C. Bottelli
- Department of Hematology; ASST Spedali Civili; Brescia Italy
| | - S. Ferrero
- Division of Hematology; University of Torino, Azienda Ospedaliero Universitaria, Città della Salute e della Scienza di Torino; Torino Italy
| | - D. Dessì
- Division of Hematology; Ospedale Businco; Cagliari Italy
| | - E. Cencini
- Unit of Hematology; Azienda Ospedaliera Universitaria Senese; Siena Italy
| | - E. Pennese
- Lymphoma Unit, Department of Hematology; Ospedale Spirito Santo; Pescara Italy
| | | | - C. Mammi
- GRADE; Gruppo Amici dell'Ematologia Foundation; Reggio Emilia Italy
| | - S. Luminari
- Hematology; Azienda USL-IRCCS; Reggio Emilia Italy
| | - A. Tucci
- Department of Hematology; ASST Spedali Civili; Brescia Italy
| |
Collapse
|
6
|
Balzarotti M, Ricardi U, Spina M, Monagheddu C, Tucci A, Cavallo F, Zanni M, Arcari A, Rusconi C, Sartori R, Merli F, Re F, Vitolo U, Dessi D, Melis L, Gaidano G, Chiti A, Deidda M, Santoro A, Ciccone G, Chauvie S, Cabras M. PET-DRIVEN RADIOTHERAPY IN PATIENTS WITH LOW RISK DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): THE DLCL10 MULTICENTER PHASE 2 TRIAL BY FONDAZIONE ITALIANA LINFOMI (FIL). Hematol Oncol 2019. [DOI: 10.1002/hon.62_2630] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- M. Balzarotti
- Medical Oncology and Hematology; Humanitas Clinical and Research Hospital-IRCCS-Humanitas University; Rozzano Milano Italy
| | - U. Ricardi
- Radiotherapy; AOU Città della Salute e della Scienza, University of Torino; Torino Italy
| | - M. Spina
- Medical Oncology; IRCCS CRO; Aviano (PN) Italy
| | - C. Monagheddu
- Epidemiologia Clinica e Valutativa; AOU Città della Salute e della Scienza e CPO; Torino Italy
| | - A. Tucci
- Hematology; Spedali Civili; Brescia
| | - F. Cavallo
- Hematology; Universita' Citta' della Salute e della Scienza; Torino Italy
| | - M. Zanni
- Hematology; ASO ss Antonio e Biagio e Arrigo; Alessandria Italy
| | - A. Arcari
- Hematology; Ospedale Guglielmo da Saliceto; Piacenza Italy
| | - C. Rusconi
- Hemtaology; ASST Grande Ospedale Metropolitano Niguarda; Milano Italy
| | - R. Sartori
- Hematology; Azienda ULSS 2 Marca Trevigiana; Castelfranco Veneto Treviso Italy
| | - F. Merli
- Hematology; Arcispedale Santa Maria Nuova; Reggio Emilia Italy
| | - F. Re
- Hematology; AOU Parma; Parma Italy
| | - U. Vitolo
- Hematology; AO Città della Salute e della Scienza; Torino Italy
| | - D. Dessi
- Hematology; Ospedale Oncologico Armando Businco; Cagliari Italy
| | - L. Melis
- Nuclear Medicine; Ospedale Oncologico Armando Businco; Cagliari Italy
| | - G. Gaidano
- Hematology; AOU Maggiore della Carità di Novara; Novara Italy
| | - A. Chiti
- Nuclear Medicine; Humanitas Clinical and Research Hospital-IRCCS - Humanitas University; Rozzano Milano Italy
| | - M. Deidda
- Radiotherapy; Ospedale Oncologico Armando Businco; Cagliari Italy
| | - A. Santoro
- Medical Oncology and Hematology; Humanitas Clinical and Research Hospital-IRCCS-Humanitas University; Rozzano Milano Italy
| | - G. Ciccone
- Epidemiologia Clinica e Valutativa; AOU Città della Salute e della Scienza e CPO; Torino Italy
| | - S. Chauvie
- Medical Physics; Santa Croce e Carle Hospital; Cuneo Italy
| | - M. Cabras
- Hematology; Ospedale Oncologico Armando Businco; Cagliari Italy
| |
Collapse
|
7
|
Chiappella A, Carniti C, Evangelista A, Re A, Cabras M, Stefoni V, Castellino C, Congiu A, Pinto A, Zanni M, Rusconi C, Molinari A, Ciancia R, Baldini L, Nassi L, Re F, Tani M, Ilariucci F, Cavallo F, Santoro A, Volpetti S, Dodero A, Pileri S, Ciccone G, Corradini P. PHASE II FIL-PTCL13 STUDY OF ROMIDEPSIN-CHOEP FOLLOWED BY HIGH-DOSE CHEMOTHERAPY AND TRANSPLANTATION IN UNTREATED PERIPHERAL T-CELL LYMPHOMAS. Hematol Oncol 2019. [DOI: 10.1002/hon.3_2632] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- A. Chiappella
- Ematologia; AOU Città della Salute e della Scienza di Torino; Torino Italy
| | - C. Carniti
- Ematologia; Università degli Studi di Milano; Milano Italy
| | - A. Evangelista
- SSD Epidemiologia Clinica e Valutativa; Clinical Trial Center, AOU Città della Salute e della Scienza di Torino e CPO Piemonte; Torino Italy
| | - A. Re
- Ematologia; ASTT Spedali Civili di Brescia; Brescia Italy
| | - M.G. Cabras
- Ematologia; Ospedale Oncologico Armando Businco; Cagliari Italy
| | - V. Stefoni
- Ematologia; Policlinico S.Orsola-Malpighi, Istituto di Ematologia "Seragnoli"; Bologna Italy
| | - C. Castellino
- Ematologia e Trapianto di Midollo Osseo; AO Santa Croce e Carle; Cuneo Italy
| | - A.G. Congiu
- Ematologia; Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia; Genova Italy
| | - A. Pinto
- Ematologia Oncologica; Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale; Napoli Italy
| | - M. Zanni
- Ematologia; AO SS Antonio e Biagio e Cesare Arrigo; Alessandria Italy
| | - C. Rusconi
- Ematologia; ASST Grande Ospedale Metropolitano Niguarda; Milano Italy
| | | | - R. Ciancia
- Oncoematologia; trapianti emopoietici e terapie cellulari, Centro di Riferimento Oncologico CRO, IRCCS; Aviano Italy
| | - L. Baldini
- Ematologia; Ospedale Maggiore Policlinico - Fondazione IRCCS Ca' Granda; Milano Italy
| | - L. Nassi
- Ematologia; AOU Maggiore della Carità di Novara; Novara Italy
| | - F. Re
- Ematologia e CTMO; AOU Ospedale Maggiore di Parma; Parma Italy
| | - M. Tani
- Ematologia; Ospedale Santa Maria delle Croci; Ravenna Italy
| | - F. Ilariucci
- Ematologia; Azienda Ospedaliera Arcispedale Santa Maria Nuova - IRCCS; Reggio Emilia Italy
| | - F. Cavallo
- Ematologia; Università degli Studi - AOU Città della Salute e della Scienza di Torino; Torino Italy
| | - A. Santoro
- Ematologia; Istituto Clinico Humanitas; Rozzano Italy
| | - S. Volpetti
- Ematologia; ASUI Santa Maria della Misericordia; Udine Italy
| | - A. Dodero
- Ematologia; Fondazione IRCCS Istituto Nazionale dei Tumori; Milano Italy
| | - S.A. Pileri
- Emopatologia; Istituto Europeo Oncologico IRCCS; Milano Italy
| | - G. Ciccone
- SSD Epidemiologia Clinica e Valutativa; Clinical Trial Center, AOU Città della Salute e della Scienza di Torino e CPO Piemonte; Torino Italy
| | - P. Corradini
- Ematologia; Fondazione IRCCS Istituto Nazionale dei Tumori - Università degli Studi di Milano; Milano Italy
| |
Collapse
|
8
|
Ferrero S, Ladetto M, Beldjord K, Drandi D, Stelitano C, Bernard S, Castagnari B, Bouabdallah K, Cesaretti M, Alvarez I, Gressin R, Ponzoni M, Tripodo C, Traverse-Glehen A, Baseggio L, Liberati A, Merli M, Tessoulin B, Patti C, Cabras M, Feugier P, Pozzi S, Zucca E, Iannitto E, Thieblemont C. FIRST APPLICATION OF MINIMAL RESIDUAL DISEASE ANALYSIS IN SPLENIC MARGINAL ZONE LYMPHOMA TRIALS: PRELIMINARY RESULTS FROM BRISMA/IELSG36 PHASE II STUDY. Hematol Oncol 2019. [DOI: 10.1002/hon.39_2630] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- S. Ferrero
- Hematology Division; Università di Torino, Molecular Biotechnologies and Health Sciences; Torino Italy
| | - M. Ladetto
- Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo; SC Ematologia; Alessandria Italy
| | - K. Beldjord
- Hemato-Oncology; Hôpital Saint-Louis; Paris France
| | - D. Drandi
- Hematology Division; Università di Torino, Molecular Biotechnologies and Health Sciences; Torino Italy
| | - C. Stelitano
- U.O.C. Ematologia; Grande Ospedale Metropolitano Bianchi Melacrino Morelli; Reggio Calabria Italy
| | - S. Bernard
- Hemato-Oncology; Hôpital Saint-Louis; Paris France
| | - B. Castagnari
- UOC of Hematology; Hospital Santa Maria delle Croci; Ravenna Italy
| | | | - M. Cesaretti
- University of Modena and Reggio Emilia; Department of Diagnostic, Clinical and Public Health Medicine; Modena Italy
| | - I. Alvarez
- AUSL Reggio Emilia/IRCCS; Arcispedale Santa Maria Nuova, UOC of Hematology; Reggio Emilia Italy
| | - R. Gressin
- Grenoble Alpes University Hospital; Department of Hematology; Grenoble France
| | - M. Ponzoni
- Pathology Unit; Ateneo Vita-Salute and San Raffaele Scientific Institute; Milano Italy
| | - C. Tripodo
- Department of Health Science; Human Pathology Section,Tumor Immunology Unit, University of Palermo; Palermo Italy
| | | | - L. Baseggio
- Pierre-Benite; Cytology, CHU Lyon; Lyon France
| | - A. Liberati
- University of Perugia; Oncology-Hematology, Santa Maria Hospital; Terni Italy
| | - M. Merli
- ASST Settelaghi; University Hospital Ospedale di Circolo e Fondazione Macchi; Varese Italy
| | | | - C. Patti
- Division of Hematology; Azienda Ospedali Riuniti Villa Sofia-Cervello; Palermo Italy
| | - M. Cabras
- Ospedale Businco; Division of Hematology; Cagliari Italy
| | - P. Feugier
- University Hospital of Nancy; Department of Haematology; Nancy France
| | - S. Pozzi
- Unit of Target Therapy in Onco-Hematology and Osteoncology, University of Modena and Reggio Emilia, Department of Oncology and Hematology; Modena Cancer Center; Modena Italy
| | - E. Zucca
- Institute of Oncology Research; Università della Svizzera Italiana (USI), IOSI, Oncology Institute of Southern Switzerland and IOR; Bellinzona Switzerland
| | - E. Iannitto
- Department of Oncology; “La Maddalena”, Onco-Hematology and BMT Unit; Palermo Italy
| | | |
Collapse
|
9
|
Cabras M, Gambino A, Broccoletti R, Arduino PG. Desquamative gingivitis: a systematic review of possible treatments. J BIOL REG HOMEOS AG 2019; 33:637-642. [PMID: 30888131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Affiliation(s)
- M Cabras
- Department of Surgical Sciences, Oral Medicine Section, CIR-Dental School, University of Turin, Turin, Italy
| | - A Gambino
- Department of Surgical Sciences, Oral Medicine Section, CIR-Dental School, University of Turin, Turin, Italy
| | - R Broccoletti
- Department of Surgical Sciences, Oral Medicine Section, CIR-Dental School, University of Turin, Turin, Italy
| | - P G Arduino
- Department of Surgical Sciences, Oral Medicine Section, CIR-Dental School, University of Turin, Turin, Italy
| |
Collapse
|
10
|
Carbone M, Cabras M, Conrotto D, Arduino PG, Garzino Demo P, Carrozzo M. Positive clinical outcome of an oral in situ
melanoma: 6 years of follow-up. Clin Exp Dermatol 2018; 43:603-605. [DOI: 10.1111/ced.13572] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/02/2017] [Indexed: 10/16/2022]
Affiliation(s)
- M. Carbone
- Department of Surgical Sciences; Oral Medicine Section; CIR Dental School; University of Turin; Via Nizza 230 10126 Turin Italy
| | - M. Cabras
- Department of Surgical Sciences; Oral Medicine Section; CIR Dental School; University of Turin; Via Nizza 230 10126 Turin Italy
| | - D. Conrotto
- Department of Surgical Sciences; Oral Medicine Section; CIR Dental School; University of Turin; Via Nizza 230 10126 Turin Italy
| | - P. G. Arduino
- Department of Surgical Sciences; Oral Medicine Section; CIR Dental School; University of Turin; Via Nizza 230 10126 Turin Italy
| | - P. Garzino Demo
- Department of Surgical Sciences; Maxillofacial Unit; University Hospital Città della Scienza e della Salute; University of Turin; Turin Italy
| | - M. Carrozzo
- Oral Medicine Department; Centre for Oral Health Research; Newcastle University; Newcastle upon Tyne UK
| |
Collapse
|
11
|
Arduino PG, Campolongo MG, Sciannameo V, Conrotto D, Gambino A, Cabras M, Ricceri F, Carossa S, Broccoletti R, Carbone M. Randomized, placebo-controlled, double-blind trial of clobetasol propionate 0.05% in the treatment of oral lichen planus. Oral Dis 2018; 24:772-777. [PMID: 29297958 DOI: 10.1111/odi.12821] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2017] [Revised: 12/18/2017] [Accepted: 12/22/2017] [Indexed: 11/29/2022]
Abstract
OBJECTIVE To perform a randomized, placebo-controlled, double-blind study, with a follow-up period of 6 months, for the use of topical clobetasol in cases of symptomatic oral lichen planus (OLP). SUBJECTS AND METHODS Thirty-two participants were analyzed, with the aims of: (I) to compare the usefulness of topically applied clobetasol propionate 0.05% (mixed with 4% hydroxyethyl cellulose gel) and 4% hydroxyethyl cellulose gel alone (considered as placebo) in the management of OLP; (II) to describe which of them is quicker in decreasing signs and reported symptoms, and (III) which is able to give the proper longer remission in the follow-up. RESULTS Symptoms improved in all clobetasol-treated patients during the first 2 months of therapy, while only 50% of placebo control group (p = .005) displayed similar results; of the remaining half, 12.5% did experienced a worsening while 37.5% remained stable. Regarding clinical signs, 87.5% of clobetasol-treated patients improved, while only 62.5% of the placebo-treated patients had a positive response (p = .229). CONCLUSIONS It is possible to report that clobetasol, at this dosage, has been more effective than a placebo at provoking symptoms improvement in subjects affected by atrophic-erosive oral lesions.
Collapse
Affiliation(s)
- P G Arduino
- Department of Surgical Sciences, CIR-Dental School, University of Turin, Turin, Italy
| | - M G Campolongo
- Department of Surgical Sciences, CIR-Dental School, University of Turin, Turin, Italy
| | - V Sciannameo
- Unit of Epidemiology, Regional Health Service ASL TO3, Grugliasco, Italy
| | - D Conrotto
- Department of Surgical Sciences, CIR-Dental School, University of Turin, Turin, Italy
| | - A Gambino
- Department of Surgical Sciences, CIR-Dental School, University of Turin, Turin, Italy
| | - M Cabras
- Department of Surgical Sciences, CIR-Dental School, University of Turin, Turin, Italy
| | - F Ricceri
- Unit of Epidemiology, Regional Health Service ASL TO3, Grugliasco, Italy
| | - S Carossa
- Department of Surgical Sciences, CIR-Dental School, University of Turin, Turin, Italy
| | - R Broccoletti
- Department of Surgical Sciences, CIR-Dental School, University of Turin, Turin, Italy
| | - M Carbone
- Department of Surgical Sciences, CIR-Dental School, University of Turin, Turin, Italy
| |
Collapse
|
12
|
Gambino A, Cabras M, Fusco V, Bertetto O, De Martino I, Alessio M, Numico G. Osteonecrosis of jaw (ONJ) after antiresorptive treatment (bisphosphonates, denosumab) of cancer-treatment induced bone loss (CTIBL): a negligible risk? Ann Oncol 2017. [DOI: 10.1093/annonc/mdx436.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
13
|
Chiappella A, Agostinelli C, Martelli M, Evangelista A, Fabbri M, Melle F, Motta G, Righi S, Novero D, Balzarotti M, Cabras M, Carella A, Gotti M, Pavone V, Tucci A, Ladetto M, Gaidano G, Vitolo U, Pileri S. BIODLCL04: THE PROGNOSTIC ROLE OF CELL OF ORIGIN PROFILE, MYC, BCL2, AND TP53 IN UNTREATED POOR-RISK DIFFUSE LARGE B-CELL LYMPHOMA. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_12] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- A. Chiappella
- AOU Città della Salute e della Scienza di Torino; On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - C. Agostinelli
- AOU Città della Salute e della Scienza di Torino; On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - M. Martelli
- AOU Città della Salute e della Scienza di Torino; On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - A. Evangelista
- AOU Città della Salute e della Scienza di Torino; On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - M. Fabbri
- AOU Città della Salute e della Scienza di Torino; On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - F. Melle
- AOU Città della Salute e della Scienza di Torino; On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - G. Motta
- AOU Città della Salute e della Scienza di Torino; On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - S. Righi
- AOU Città della Salute e della Scienza di Torino; On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - D. Novero
- AOU Città della Salute e della Scienza di Torino; On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - M. Balzarotti
- AOU Città della Salute e della Scienza di Torino; On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - M.G. Cabras
- AOU Città della Salute e della Scienza di Torino; On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - A.M. Carella
- AOU Città della Salute e della Scienza di Torino; On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - M. Gotti
- AOU Città della Salute e della Scienza di Torino; On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - V. Pavone
- AOU Città della Salute e della Scienza di Torino; On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - A. Tucci
- AOU Città della Salute e della Scienza di Torino; On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - M. Ladetto
- AOU Città della Salute e della Scienza di Torino; On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - G. Gaidano
- AOU Città della Salute e della Scienza di Torino; On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - U. Vitolo
- AOU Città della Salute e della Scienza di Torino; On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - S.A. Pileri
- AOU Città della Salute e della Scienza di Torino; On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| |
Collapse
|
14
|
Chiappella A, Carniti C, Ceccarelli M, Cabras M, Re A, Salvi F, Santoro A, Stefoni V, Pileri S, Ciccone G, Corradini P. FIL-PTCL13: PHASE IB/II STUDY OF ROMIDEPSIN/CHOEP FOLLOWED BY HIGH-DOSE CHEMOTHERAPY AND TRANSPLANTATION IN UNTREATED PERIPHERAL T-CELL LYMPHOMAS. Hematol Oncol 2017. [DOI: 10.1002/hon.2440_10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- A. Chiappella
- Hematology; AOU Città della Salute e della Scienza, On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - C. Carniti
- Division of Hematology and Bone Marrow Transplant, Fondazione IRCCS Istituto Nazionale dei Tumori; Department of Oncology and Hemato-Oncology; University of Milan, On behalf of Fondazione Italiana Linfomi (FIL); Milan Italy
| | - M. Ceccarelli
- Unit of Clinical Epidemiology, CPO; AOU Città della Salute e della Scienza di Torino, On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - M.G. Cabras
- Hematology, Ospedale “A. Businco” Cagliari; Haematology & Transplant Centre “Wilma Deplano”, On behalf of Fondazione Italiana Linfomi (FIL); Cagliari Italy
| | - A. Re
- Hematology, Azienda Ospedaliera Spedali Civili di Brescia; On behalf of Fondazione Italiana Linfomi (FIL); Brescia Italy
| | - F. Salvi
- Hematology, Azienda Ospedaliera Nazionale SS.Antonio e Biagio e C. Arrigo; On behalf of Fondazione Italiana Linfomi (FIL); Alessandria Italy
| | - A. Santoro
- Hematology, Istituto Clinico Humanitas and IRCCS; On behalf of Fondazione Italiana Linfomi (FIL); Rozzano Italy
| | - V. Stefoni
- Hematology, Istituto L e A Seragnoli, Policlinico S. Orsola-Malpighi; On behalf of Fondazione Italiana Linfomi (FIL); Bologna Italy
| | - S. Pileri
- Institute of Hematology "L. e A. Seràgnoli", Universita degli Studi di Bologna and Haematopathology Unit; Istituto Europeo di Oncologia, On behalf of Fondazione Italiana Linfomi (FIL); Milan Italy
| | - G. Ciccone
- Unit of Clinical Epidemiology, CPO; AOU Città della Salute e della Scienza di Torino, On behalf of Fondazione Italiana Linfomi (FIL); Torino Italy
| | - P. Corradini
- Division of Hematology and Bone Marrow Transplant, Fondazione IRCCS Istituto Nazionale dei Tumori; Department of Oncology and Hemato-Oncology; University of Milan, On behalf of Fondazione Italiana Linfomi (FIL); Milan Italy
| |
Collapse
|
15
|
Carcieri P, Broccoletti R, Giacometti S, Gambino A, Conrotto D, Cabras M, Arduino PG. Favourably effective formulation of sodium iodide and salicylic acid plus professional hygiene in patients affected by desquamative gingivitis. J BIOL REG HOMEOS AG 2016; 30:1141-1145. [PMID: 28078866] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
The aim of this prospective pilot study was to evaluate the efficiency of an oral hygiene protocol, in combination with a solution of sodium iodide associated to salicylic acid (SISA), in patients affected by desquamative gingivitis (DG). Twenty patients not totally responding to conventional topical therapies, were selected. They received oral hygiene instructions with non-surgical periodontal therapy in a 21-day cohort study (during 3 weekly appointments). The SISA was used at the end of each session, with an impregnated gauze (with 5 ml of the solution) applied for 15 minutes for the upper jaw, and for a further 15 minutes with a new gauze for the lower. Evaluated clinical outcome variables included the full mouth plaque (FMPS) and bleeding (FMBS) scores, probing depth, patient related outcome and clinical gingival signs. Two months after concluding the planned protocol, a statistically significant reduction was observed for FMPS (P=0.032), FMBS (P=0.038), reported pain (P=0.000) and gingival clinical improvement (P=0.005). Topical application of SISA and professional oral hygiene procedures are connected with improvement of gum status, and decrease of related pain in subjects affected by severe DG.
Collapse
Affiliation(s)
- P Carcieri
- Department of Surgical Sciences, Cir-Dental School, University of Turin, Italy
| | - R Broccoletti
- Department of Surgical Sciences, Cir-Dental School, University of Turin, Italy
| | - S Giacometti
- Department of Surgical Sciences, Cir-Dental School, University of Turin, Italy
| | - A Gambino
- Department of Surgical Sciences, Cir-Dental School, University of Turin, Italy
| | - D Conrotto
- Department of Surgical Sciences, Cir-Dental School, University of Turin, Italy
| | - M Cabras
- Department of Surgical Sciences, Cir-Dental School, University of Turin, Italy
| | - P G Arduino
- Department of Surgical Sciences, Cir-Dental School, University of Turin, Italy
| |
Collapse
|
16
|
Arduino P, Cabras M, Broccoletti R. Efficacia di un trattamento a base di oli iperossidati nelle ulcere orali traumatiche: Studio pilota. Dental Cadmos 2016. [DOI: 10.1016/s0011-8524(16)30052-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
17
|
Restivo A, Zorcolo L, D'Alia G, Cabras M, Casula G. Successful endoscopic removal of a large calcified cyst impacted in the sigmoid lumen. Endoscopy 2011; 43 Suppl 2 UCTN:E125. [PMID: 21425008 DOI: 10.1055/s-0030-1256201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/10/2022]
Affiliation(s)
- A Restivo
- Dipartimento di Chirurgia e Centro Patologia del Colon-Retto, Università di Cagliari, Cagliari, Italy
| | | | | | | | | |
Collapse
|
18
|
Restivo A, Zorcolo L, D'Alia G, Cabras M, Casula G. Colonic obstruction caused by calcified hepatic hydatid cyst migrated into the left colon. Endoscopy 2010; 42 Suppl 2:E169-70. [PMID: 20556719 DOI: 10.1055/s-0029-1244176] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Affiliation(s)
- A Restivo
- Dipartimento di Chirurgia e Centro Patologia del Colon-Retto, Università di Cagliari, Cagliari, Italy.
| | | | | | | | | |
Collapse
|
19
|
Targhetta C, Cabras M, Angelucci E. Risk of HBV liver disease in isolated antiHbc patients receiving immuno-chemotherapy for non Hodgkin lymphoma. Haematologica 2008; 93:e66. [DOI: 10.3324/haematol.13750] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
20
|
Cabras P, Caboni P, Cabras M. Analysis by hplc of ryanodine and dehydroryanodine residues on fruits and in ryania powdery wood. J Agric Food Chem 2001; 49:3161-3163. [PMID: 11453746 DOI: 10.1021/jf010224g] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
A simple and rapid HPLC method to evaluate residues of the major ryanoids (ryanodine and dehydroryanodine) on three fruits (olives, apples, and pears) has been developed. The pesticides were extracted from the fruits with hexane and acetone solution (1:1, v/v). Cleanup was carried out with aminopropyl-bonded silica cartridges. This method is characterized by recovery >75%, precision <11% RSD, and sensitivity of 0.020 mg/kg. The method can also be used to determine the level of active ingredients in ryania powdery wood.
Collapse
Affiliation(s)
- P Cabras
- Dipartimento di Tossicologia, Università di Cagliari, via Ospedale 72, 09124 Cagliari, Italy.
| | | | | |
Collapse
|
21
|
Scintu F, D'Alia G, Cabras M, Zorcolo L, Melis M, Marongiu L, Casula G. The impact of an incomplete preoperative colonoscopy in patients with colorectal cancer. Chir Ital 2000; 52:103-7. [PMID: 10832535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/16/2023]
Abstract
Total large bowel evaluation remains an essential step in the treatment of patients with colorectal cancer (CRC). Colonoscopy is the gold standard in the evaluation of the colon for colorectal tumors, but may be incomplete due to tumor obstruction, which is a frequent event in distal cancers. Double-contrast barium enema has a lower accuracy and is not ideal in the presence of signs of obstruction. In theory, intraoperative colonoscopy is a valid alternative, but its routine use is impeded by various practical limitations. Preoperative survey of the colon in 521 consecutive patients treated for CRC in our department was based on colonoscopy (92.5%). Our series was characterised by a high percentage of distal lesions (76.4%) and therefore by a high percentage of incomplete preoperative colonoscopies (50.4%) due to tumor obstruction. In the presence of an incomplete preoperative colonoscopy, we evaluated the entire colon with a double-contrast barium enema in selected cases (36.7%) and with a postoperative colonoscopy within 3 months of surgery in almost all patients (93.4%). The overall rate of complete endoscopic evaluation, either pre- or postoperatively, was 96.7%. The incidence of adenomas was significantly higher in the preoperative examinations as compared to early postoperative colonoscopy. This means that in distal cancer the vast majority of polyps will be located in the distal colon and therefore included in a standard resection. Four patients (0.8%), required a second operation for treatment of a missed lesion (2 benign and 2 malignant). The need for a repeat surgery apparently did not affect the therapeutic results in these four patients. On the basis of our experience, intraoperative colonoscopy would not appear to be a mandatory procedure in all cases of incomplete preoperative evaluation of the colon. However, in the absence of prospective, randomised trials comparing intraoperative vs early postoperative colonoscopy, the dilemma as to the strategy of choice remains.
Collapse
|
22
|
Melis M, Pisano M, Zorcolo L, Cabras M, D'Alia G, Scintu F. [Recurrent esophageal obstruction by a foreign body: a case report and review of the literature]. G Chir 1999; 20:490-4. [PMID: 10645067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/15/2023]
Abstract
The Authors report a clinical case of a patient endoscopically treated for recurrent oesophageal obstruction by a foreign body. A review of the recent medical literature confirms that immediate endoscopic treatment is the best approach in the oesophageal retention of foreign bodies.
Collapse
Affiliation(s)
- M Melis
- Università degli Studi di Cagliari
| | | | | | | | | | | |
Collapse
|
23
|
Affiliation(s)
- F Scintu
- Dept. of General Surgery II, University of Cagliari, Binaghi Hospital, Italy.
| | | | | | | | | |
Collapse
|
24
|
Polo M, Cabras M, Licheri S, Polo F. [A case of lithiasis and stenosis of the urethra. Diagnostic and therapeutic problems]. MINERVA UROL NEFROL 1990; 42:235-8. [PMID: 2095640] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
The association of urethral stenosis and stones is not frequent. The urethral stenosis, particularly common in males, recognizes, as predisposing causes, urethritis, IPB, perineal trauma, neurogenic bladder and, last, but not the least important, endoscopic treatments or repeated catheterism. The authors report a case of a 42 year old man who underwent, for urolithiasis, several endoscopic examinations, which became urethral-stenosis with stones within four years. With responsible and critical behaviour, etiology, the diagnostic procedures and the therapy (invasive or not) of the urethral-stenosis are examined and evaluated. Diagnosis must be based on a non painful approach (clinical, bacteriological, ultrasonography, uro-dynamic studies); the invasive procedures must be limited as much is possible. Whatever treatment is used, which may always give sequences or complications, a prolonged follow-up is mandatory to have an objective evaluation of the results.
Collapse
Affiliation(s)
- M Polo
- Divisione di Chirurgia Generale, USL N. 12 Ospedale G.P. Delogu, Chilarza Oristano
| | | | | | | |
Collapse
|